Ovarian Failure, Premature
7
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve
Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients
Ovarian Reserve and Matrix Metalloproteinases
Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary
Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation
Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure